List of Wound Healing Companies in Spain - 2

Aortyx is a medical device startup based in Barcelona, founded in 2018 by researchers from the Institut Químic de Sarrià and Hospital Clínic de Barcelona. The company aims to improve aortic disease management through innovative biomaterials and endovascular technologies, addressing critical needs in vascular repair. Aortyx specializes in biomimetic, bioresorbable endovascular patches that are deployed using a proprietary aortic catheter system. These patches promote tissue regeneration by encouraging cell migration and proliferation in damaged aortic walls, while mimicking the biomechanical environment of the aorta. The technology is designed to resorb over time, reducing the risks associated with permanent implants and targeting conditions like aortic dissection. With a team of nearly 20 experts in biomaterials, vascular engineering, and aortic surgery, Aortyx has secured significant funding to advance its preclinical development. The company positions itself as a pioneer in bioresorbable solutions for aortic diseases, focusing on collaboration with endovascular surgeons and hospitals.

Histocell is a clinical-stage biopharmaceutical company, specialized in developing cell therapy medicaments and novel medical devices for regenerative medicine, with a therapeutic approach focus on the control of oxidative stress. We work to improve people’s quality of life by creating new Cell Therapy medicaments. Our headquarters is located at the Bizkaia Science and Technology Park (Spain), with facilities comprising a 65 m2 GMP certified manufacturing room for cell therapy medicinal products, several laboratories for quality control and R&D activities and a 2000 m2 medical device manufacturing plant. Our team meets the maximum quality standards through GMP and ISO 9001/2000 certifications. Company's pipeline includes medical devices for promotion of Natural Wound Healing (Reoxcare® , Vexoderm®), Dermatologic Tissue Regeneration (Histoessence®, Wharton Gel Complex®, Neofibrin®) as well as Cell Therapy programs based on adipose derived mesenchymal stem cells (AMSC) for Bone regeneration and based on HC016 cellular product (proprietary technology) for Acute Spinal Cord Injury and Lung disease. Finally, Histocell, as an authorized ATMP manufacturing laboratory, offers Contract Manufacturing Services for both GMP and GMP-like manufacturing of cell therapy products.